FrancophonIA/ELRC3.0 huggingface dataset:
English: [EMEA/MB/767563/2009] The Board endorsed the fixed, flat hourly cost for 2010, which is set at the same rate as in 2009.
Estonian: [EMEA/MB/767563/2009] Haldusnõukogu kinnitas 2010. aastaks kindla määraga tunnitasu, mis võrdub 2009. aasta määraga.
English: [EMEA/MB/761723/2009; EMEA/MB/736762/2009] The Board noted the status reports on the implementation of EudraVigilance for human and veterinary medicines.
Estonian: [EMEA/MB/761723/2009; EMEA/MB/736762/2009] Haldusnõukogu võttis teadmiseks aruanded andmebaasi EudraVigilance rakendamise kohta inimtervishoius kasutatavate ravimite ja veterinaarravimite suhtes.
English: Work programme 2010 [EMEA/MB/203131/2009] The Board adopted the Work programme 2010.
Estonian: [EMEA/MB/203131/2009] Haldusnõukogu võttis vastu 2010. aasta tööplaani.
English: [EMEA/MB/752624/2009; EMEA/MB/786453/2009] The Board discussed and adopted the draft road map to 2015 for public consultation.
Estonian: [EMEA/MB/752624/2009; EMEA/MB/786453/2009] Haldusnõukogu arutas ja võttis vastu 2015. aastani ulatuva tegevuskava projekti, mis esitatakse avalikule arutelule.
English: Björn Lemmer
Estonian: Giuseppe Nisticó Björn Lemmer
English: Lisette Engwirda-Tiddens
Estonian: Arstiühingute esindaja Lisette Engwirda-Tiddens Veterinaariühingute esindaja
English: Highlights from the Executive Director
Estonian: Tegevdirektori ettekande põhipunktid
English: − Minutes of the 64th meeting of the Management Board.
Estonian: haldusnõukogu 64. koosoleku protokoll.
English: United Kingdom Kent Woods European Parliament
Estonian: Kent Woods
English: Minutes of the 65th meeting of the Management Board
Estonian: Haldusnõukogu 65. koosoleku protokoll
English: • [EMEA/MB/715154/2009] Outcome of written procedures:
Estonian: • [EMEA/MB/715154/2009] Kirjalike menetluste tulemused: inimtervishoius kasutatavate ravimite ja veterinaarravimite teaduskomiteede koosseisu muutusi käsitlevad konsultatsioonid;
English: Representative of
Estonian: Vaatlejad
English: In addition, the safety profile of the two components is well known, and there is no evidence that the combination is worse than the individual components.
Estonian: Lisaks on kahe koostisosa ohutusprofiil teada ning ei ole tõendeid, et kombinatsioon oleks kahjulikum kui selle üksikud koostisosad.
English: The full EPAR and risk management plan summary for Brimica Genuair can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst ja riskijuhtimiskava kokkuvõte Brimica Genuairi kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Aclidinium bromide has been authorised in the EU as Bretaris Genuair and Eklira Genuair since July 2012; formoterol has been marketed in the EU since the 1990s.
Estonian: Aklidiiniumbromiid on Euroopa Liidus heaks kiidetud Bretaris Genuairi ja Eklira Genuairina alates 2012. aasta juulist; formoterooli on Euroopa Liidus turustatud alates 1990. aastatest.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Brimica Genuair on 19 November 2014.
Estonian: Euroopa Komisjon andis Brimica Genuairi müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 19. novembril 2014.
English: A risk management plan has been developed to ensure that Brimica Genuair is used as safely as possible.
Estonian: Töötati välja riskijuhtimiskava, et tagada Brimica Genuairi võimalikult ohutu kasutamine.
English: What measures are being taken to ensure the safe and effective use of Brimica Genuair?
Estonian: Mis meetmed võetakse, et tagada Brimica Genuairi ohutu ja efektiivne kasutamine?
English: The recommended dose of Brimica Genuair is one inhalation twice a day.
Estonian: Brimica Genuairi soovitatav annus on üks inhalatsioon kaks korda ööpäevas.
English: What is Brimica Genuair and what is it used for?
Estonian: Mis on Brimica Genuair ja milleks seda kasutatakse?
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Brimica Genuair's benefits are greater than its risks and recommended that it be approved for use in the EU.
Estonian: Inimravimite komitee otsustas, et Brimica Genuairi kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas ravimi kasutamise Euroopa Liidus heaks kiita.
English: Other information about Brimica Genuair
Estonian: Muu teave Brimica Genuairi kohta
English: Regarding safety, the number of side effects reported with Brimica Genuair was low and did not raise any major safety concern.
Estonian: Ohutuse seisukohast oli Brimica Genuairi kohta teatatud kõrvalnähtude arv väike ning seoses sellega ei tõstatatud ühtki olulist ohutusprobleemi.
English: The main measure of effectiveness was based on changes in patients' forced expiratory volumes (FEV1, the maximum volume of air a person can breathe out in one second) after six months.
Estonian: Efektiivsuse põhinäitaja oli patsientide forsseeritud ekspiratoorse mahu (FEV1, suurim õhukogus, mida inimene suudab ühe sekundi jooksul välja hingata) muutus kuue kuu möödumisel.
English: Formoterol is a long-acting beta-2 agonist.
Estonian: Formoterool on pikatoimeline β2-agonist.
English: Brimica Genuair aclidinium bromide / formoterol fumarate dihydrate
Estonian: Brimica Genuair aklidiiniumbromiid/formoteroolfumaraatdihüdraat
English: The most common side effects (seen in around 7 patients in 100) are nasopharyngitis (inflammation of the nose and throat) and headache.
Estonian: Kõige sagedamad kõrvalnähud (võivad esineda enam kui 7 patsiendil 100st) on nasofarüngiit (nina-neelupõletik) ja peavalu.
English: In addition, as long-acting muscarinic antagonists may have an effect on the heart and blood vessels, the company that markets Brimica Genuair will provide the results of studies to further evaluate the cardiovascular safety of the medicine.
Estonian: Et pikatoimelistel muskariiniretseptori antagonistidel võib olla mõju südamele ja veresoontele, esitab Brimica Genuairi turustav ettevõte uuringutulemused ravimi kardiovaskulaarse ohutuse täiendavaks hindamiseks.
English: Brimica Genuair is a medicine used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults.
Estonian: Brimica Genuair on ravim, mida kasutatakse kroonilise obstruktiivse kopsuhaiguse sümptomite leevendamiseks täiskasvanutel.
English: However the improvement over formoterol alone was small and not considered clinically significant: FEV1 measured in the morning before the inhalation was 68 ml more with Brimica Genuair than with formoterol alone.
Estonian: Paranemine võrreldes ainult formoterooli kasutamisega oli aga väike ja seda ei peeta kliiniliselt oluliseks: hommikul enne inhalatsiooni mõõdetud FEV1 oli Brimica Genuairi kasutamisel 68 ml suurem kui ainult formoterooli kasutamisel.
English: This is a summary of the European public assessment report (EPAR) for Brimica Genuair.
Estonian: See on ravimi Brimica Genuair Euroopa avaliku hindamisaruande kokkuvõte.
English: Why is Brimica Genuair approved?
Estonian: Miks Brimica Genuair heaks kiideti?
English: Brimica Genuair has been studied in 2 main studies involving over 3,400 patients with COPD, in which it was compared with aclidinium alone, formoterol alone and placebo (a dummy treatment).
Estonian: Brimica Genuairi on uuritud kahes põhiuuringus, milles osales enam kui 3400 kroonilise obstruktiivse kopsuhaigusega patsienti ja milles võrreldi ravimit ainult aklidiini, ainult formoterooli ja platseeboga (näiv ravim).
English: This means that it widens the airways by blocking some receptors in muscle cells in the lungs called muscarinic (also known as cholinergic) receptors, which control the contraction of muscles.
Estonian: See tähendab, et ravim laiendab hingamisteid, blokeerides muskariiniretseptoriteks (tuntud ka kolinergiliste retseptoritena) nimetatavaid kopsude lihasrakkude retseptoreid, mis juhivad lihaste kokkutõmbumist.
English: The inhaler delivers 340 micrograms of aclidinium and 12 micrograms of formoterol fumarate dihydrate for each inhalation.
Estonian: Igal inhalatsioonil manustatakse inhalaatoriga 340 mikrogrammi aklidiini ja 12 mikrogrammi formoteroolfumaraatdihüdraati.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Brimica Genuair, including the appropriate precautions to be followed by healthcare professionals and patients.
Estonian: Selle alusel lisati Brimica Genuairi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
English: Results showed that, after six months of treatment, the increase in FEV1 (measured one hour after an inhalation) was 293 milliliters (ml) more with Brimica Genuair than with placebo and 118 ml more with Brimica Genuair than with aclidinium alone.
Estonian: Tulemused näitasid, et pärast kuuekuulist ravi oli FEV1 näidu paranemine (mõõdetuna üks tund pärast inhalatsiooni) Brimica Genuairi kasutamisel 293 milliliitrit (ml) suurem kui platseebo kasutamisel ning Brimica Genuairi kasutamisel 118 ml suurem võrreldes ainult aklidiini kasutamisega.
English: Brimica Genuair contains two active substances: aclidinium bromide and formoterol fumarate dihydrate.
Estonian: Brimica Genuair sisaldab kaht toimeainet: aklidiiniumbromiidi ja formoteroolfumaraatdihüdraati.
English: For practical information about using Brimica Genuair, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Brimica Genuairi kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: It is not intended to provide practical advice on how to use Brimica Genuair.
Estonian: Hindamisaruandes ei anta Brimica Genuairi kasutamise praktilisi nõuandeid.
English: Brimica Genuair is used for maintenance (regular) treatment.
Estonian: Brimica Genuairi kasutatakse säilitusraviks (tavaravi).
English: What are the risks associated with Brimica Genuair?
Estonian: Mis riskid Brimica Genuairiga kaasnevad?
English: Side effects with Brimica Genuair are similar to those with the individual components.
Estonian: Brimica Genuairi kõrvalnähud on sarnased ravimi koostisosade kõrvalnähtudega.
English: For more information about treatment with Brimica Genuair, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Brimica Genuairiga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing.
Estonian: Krooniline obstruktiivne kopsuhaigus on krooniline haigus, mille puhul hingamisteed ja kopsualveoolid on kahjustatud või blokeerunud ning see põhjustab hingamisraskusi.
English: Brimica Genuair is available as an inhalation powder in a portable inhaler device.
Estonian: Brimica Genuairi turustatakse inhalatsioonipulbrina kaasaskantavas inhalaatoris.
English: For the full list of all side effects and restrictions with Brimica Genuair, see the package leaflet.
Estonian: Brimica Genuairi kohta teatatud kõrvalnähtude ja piirangute täielik loetelu on pakendi infolehel.
English: The two active substances in Brimica Genuair, aclinidium bromide and formoterol fumarate dihydrate, work by keeping the airways open and allowing the patient to breathe more easily.
Estonian: Brimica Genuairi kaks toimeainet aklidiiniumbromiid ja formoteroolfumaraatdihüdraat hoiavad hingamisteed avatuna ja võimaldavad patsiendil kergemini hingata.
English: How does Brimica Genuair work?
Estonian: Kuidas Brimica Genuair toimib?
English: The CHMP noted that Brimica Genuair was shown to significantly improve lung function in patients with COPD compared with placebo, although the improvement observed when Brimica Genuair was compared with one of the components on its own, formoterol, was small.
Estonian: Inimravimite komitee pidas tõendatuks, et võrreldes platseeboga parandab Brimica Genuair tunduvalt kroonilise obstruktiivse kopsuhaigusega patsientide kopsutalitlust, kuigi Brimica Genuairi võrdlemisel selle koostisosa formoterooliga oli paranemine väike.
English: How is Brimica Genuair used?
Estonian: Kuidas Brimica Genuairi kasutatakse?
English: Brimica Genuair was also shown to increase the percentage of patients who had an improvement in breathlessness compared with placebo.
Estonian: Samuti selgus, et võrreldes platseeboga suureneb Brimica Genuairi kasutamisel nende patsientide osakaal, kellel esineb vähem hingeldamist.
English: Aclidinium bromide is a long-acting muscarinic antagonist.
Estonian: Aklidiiniumbromiid on pikatoimeline muskariiniretseptori antagonist.
English: Brimica Genuair can only be obtained with a prescription.
Estonian: Brimica Genuair on retseptiravim.
English: What benefits of Brimica Genuair have been shown in studies?
Estonian: Milles seisneb uuringute põhjal Brimica Genuairi kasulikkus?
English: When it attaches to these receptors, it causes the muscles to relax, which keeps the airways open and helps with the patient's breathing.
Estonian: Selle toimel lihased lõõgastuvad, hoides hingamisteed avatuna ja aidates patsiendil kergemini hingata.
English: Long-acting muscarinic antagonists and long-acting beta-2 agonists are commonly combined in the management of COPD.
Estonian: Pikatoimeliste muskariiniretseptori antagonistide ja pikatoimeliste β2-agonistide koos kasutamine on kroonilise obstruktiivse kopsuhaiguse ravis tavaline.
English: When aclidinium bromide is inhaled, it causes the muscles of the airways to relax, helping to keep the airways open and allowing the patient to breathe more easily.
Estonian: Inhaleeritav aklidiiniumbromiid lõõgastab hingamisteede lihaseid, hoides hingamisteed avatuna, nii et patsiendil on kergem hingata.
English: For detailed information on how to use the inhaler correctly, see the instructions in the package leaflet.
Estonian: Inhalaatori üksikasjalik kasutusjuhend on pakendi infolehel.
English: It works by attaching to receptors known as beta-2 receptors found in the muscles of the airways.
Estonian: See seondub hingamisteede lihastes leiduvate β2retseptoritega.
English: Dry them.
Estonian: Kuivatage need.
English: It should be noted that the literature studies may have limitations.
Estonian: Peab märkima, et kirjandusandmed võivad olla piiratud.
English: These agents include medicinal products such as:
Estonian: Need ained hõlmavad selliseid ravimeid, nagu:
English: In some cases the bleeding may not be obvious.
Estonian: Mõnel juhul ei pruugi veritsus olla ilmne.
English: No major bleeding occurred.
Estonian: Ühtegi suurt verejooksu ei tekkinud.
English: Store below 25 °C.
Estonian: Hoida temperatuuril kuni 25°C.
English: 2) Sit or lie in a comfortable position so you are relaxed.
Estonian: 2) Istuge või lamage mugavas asendis, mis võimaldab lõdvestumist.
English: The usual duration of treatment is 2 to 8 days.
Estonian: Tavaline ravikestus on 2 kuni 8 päeva.
English: There is no information available concerning the first trimester.
Estonian: Esimese trimestri kohta andmed puuduvad.
English: The patients were followed for three months.
Estonian: Patsiente jälgiti kolm kuud.
English: They resolve after a few days and should not cause treatment discontinuation.
Estonian: Need lahenevad mõne päevaga ja ei tohi põhjustada ravi katkestamist.
English: Other medicines and Thorinane
Estonian: Muud ravimid ja Thorinane
English: The patients had to be followed up to 30 days.
Estonian: Patsiente pidi jälgima kuni 30 päeva.
English: Anti-Xa levels are still detectable at these time points, and these delays are not a guarantee that neuraxial hematoma will be avoided.
Estonian: Anti-Xa tase on neil ajahetkedel endiselt tuvastatav ja need viivitused ei garanteeri neuraksiaalse hematoomi vältimist.
English: • When you go home, you may need to continue to use Thorinane and give it yourself (see instructions below on how to do this).
Estonian: • Kui lähete koju, võib olla vajalik jätkata Thorinane kasutamist ja manustada seda ise (vt allolevaid juhiseid, kuidas seda teha).
English: Thorinane works in two ways.
Estonian: Thorinane toimib kahel viisil:
English: Intra-patient and inter-patient variability is low.
Estonian: Patsientidevaheline ja patsiendikohane varieeruvus on vähene.
English: A total of 1,102 patients were enrolled in the study, and 1,073 patients were treated.
Estonian: Kokku kaasati uuringusse 1102 patsienti, kellest sai ravi 1073 patsienti.
English: Prophylaxis should be continued until the patient no longer has significantly reduced mobility.
Estonian: Jätkata profülaktikat, kuni patsiendi liikuvus pole enam märgatavalt vähenenud.
English: NSTEMI type of heart attack:
Estonian: NSTEMI tüüpi infarkt:
English: Treatment continued for 6 to 14 days (median duration 7 days).
Estonian: Ravi kestis 6 kuni 14 päeva (mediaanne kestus 7 päeva).
English: Talk to your doctor or pharmacist before using Thorinane if:
Estonian: Rääkige oma arsti või apteekriga enne Thorinane kasutamist, kui:
English: You should tell your doctor straight away
Estonian: Rääkige otsekohe oma arstiga,
English: Do not try to inject yourself if you have not been trained how to do so.
Estonian: Ärge proovige end ise süstida, kui te ei ole vastavat väljaõpet saanud.
English: • If you are going to have an operation your first injection will be usually given 2 hours or 12 hours before your operation.
Estonian: • Kui lähete operatsioonile, siis esimene süst tehakse teile tavaliselt 2 tundi või 12 tundi enne operatsiooni.
English: Patients must be aware that these symptoms may occur and if so, that they should inform their primary care physician.
Estonian: Patsiendid peavad olema teadlikud, et need sümptomid võivad ilmneda ja kui see juhtub, tuleb neil teavitada enda perearsti.
English: 8) Remove the needle by pulling it straight out.
Estonian: 8) Eemaldage nõel, tõmmates selle otse välja.
English: If such use is considered absolutely necessary, the decision must be made only after a careful individual benefit risk assessment.
Estonian: Kui sellist kasutamist peetakse hädavajalikuks, tuleb otsus teha pärat hoolikat individuaalset kasu ja riski hindamist.
English: CHINA
Estonian: HIINA
English: If you forget to give yourself a dose, have it as soon as you remember.
Estonian: Kui olete annuse süstimise unustanud, tehke seda niipea, kui teile meelde tuleb.
English: Special attention and compliance with the instructions for use specific to each proprietary medicinal product are therefore required.
Estonian: Seetõttu on vajalik eritähelepanu ja iga konkreetse ravimpreparaadi kasutamisjuhiste järgimine.
English: Your doctor should discuss this with you.
Estonian: Teie arst peab teiega sel teemal nõu.
English: - Decide where you are going to inject the medicine.
Estonian: - Otsustage, kuhu ravimit süstida.
English: The benefit is not established for a treatment longer than 14 days.
Estonian: Üle 14 päeva kestva ravi kasu ei ole kindlaks tehtud.
English: Some of these cases have been fatal.
Estonian: Mõned juhud on lõppenud surmaga.
English: This should be at least 5 cm away from your belly button and out towards your sides.
Estonian: See peab jääma vähemalt 5 cm kaugusele nabast, suunaga külje poole.
English: If not, use another syringe.
Estonian: Vastasel juhul võtke teine süstal.
English: This helps your body to break them down and stops them from causing you harm.
Estonian: See aitab teie organismil neid lõhustada ja peatada teile kahju tekitamise;
English: If you are able to give this medicine to yourself, your doctor or nurse will show you how to do this.
Estonian: Kui suudate endale ise seda ravimit süstida, näitab arst või meditsiiniõde teile, kuidas seda teha.
English: This is because it needs to be given as an injection.
Estonian: Põhjuseks on see, et seda tuleb süstida.
English: Enoxaparin sodium should be used during pregnancy only if the physician has established a clear need.
Estonian: Naatriumenoksapariini tohib raseduse ajal kasutada ainult juhul, kui arst on tuvastanud selge vajaduse.
English: 6) Hold the syringe so that the needle is pointing downwards (vertically at a 90º angle).
Estonian: 6) Hoidke süstalt nii, et nõel on suunaga alla (vertikaalselt 90º nurga alla).
English: Once you have removed the cap, do not allow the needle to touch anything.
Estonian: Pärast kaitse eemaldamist ärge laske nõelal millegi vastu puutuda.
English: Like other similar medicines (medicines to reduce blood clotting), Thorinane may cause bleeding which may potentially be life-threatening.
Estonian: Nagu teisedki sarnased ravimid (verehüübivust vähendavad ravimid) võib Thorinane põhjustada veritsusi, mis võivad olla potentsiaalselt eluohtlikud.
English: These included major haemorrhages, reported at most in 4.2 % of the patients (surgical patients).
Estonian: Nende hulka on arvatud suured verejooksud, millest on teatatud peamiselt 4,2 % patsientidest (kirurgilised patsiendid).
English: • are currently using medicines which affect bleeding (see section below - Other medicines).
Estonian: • kasutate hetkel veritsust mõjutavaid ravimeid (vt allpool lõik - „Teised ravimid“).
English: The amount of Thorinane given to you will depend on your age and the kind of heart attack you have had.
Estonian: Teile manustatava Thorinane annus sõltub teie vanusest ja sellest, milline südameinfarkt teil oli.
English: Retroperitoneal and intracranial haemorrhages were always considered major.
Estonian: Retroperitoneaalsed ja intrakraniaalsed verejooksud arvestati alati suurtena.
English: - Make sure you know how much you are going to inject.
Estonian: - Veenduge, et teate, kui palju ravimit endale süstida.
English: Overall list of possible side effects:
Estonian: Võimalike kõrvaltoimete üldine loetelu:
English: Operations and anesthetics
Estonian: Operatsioonid ja anesteetikumid
English: Within each system organ class, adverse reactions are presented in order of decreasing seriousness.
Estonian: Igas organsüsteemi klassis on kõrvaltoimed esitatud tõsiduse kahanemise järjekorras.
English: Use in children and adolescents The safety and efficacy of Thorinane has not been evaluated in children or adolescents.
Estonian: Kasutamine lastel ja noorukitel Thorinane ohutust ja efektiivsust lastel või noorukitel ei ole hinnatud.
English: At higher doses, increases in activated partial thromboplastin time (aPTT), and activated clotting time (ACT) may occur.
Estonian: Suuremate annuste korral kasvab aktiveeritud osalise tromboplastiini aeg (aPTT) ja võib ilmneda aktiveeritud hüübimisaeg (ACT).
English: The efficacy data are provided in the table below.
Estonian: Efektiivsuse andmed on esitatud järgnevas tabelis.
English: Note for the pre-filled syringes fitted with an automatic safety system: The safety system is triggered at the end of the injection (see instructions in section 6.6).
Estonian: Süstlid on varustatud automaatse ohutussüsteemiga: ohutussüsteem vallandub süstimise lõpus (vt juhiseid lõigus 6.6).
English: Close the container lid tightly and place the container out of reach of children.
Estonian: Sulgege konteinerikaas kindlalt ja asetage konteiner laste eest kättesaamatusse kohta.
English: • Laboratory tests
Estonian: • Laboriuuringud
English: Steady-state is achieved on the second day of treatment.
Estonian: Püsikontsentratsioon saavutatakse teisel ravipäeval.
English: This difference persisted at three months [13.8% vs. 5.5% (n=23 vs 9), p=0.01].
Estonian: Erinevus püsis pärast 3 kuud (13,8% vs 5,5% (n=23 vs 9); p=0,01.
English: 3) Choose an area on the right or left side of your stomach.
Estonian: 3) Valige süstekoht kõhu paremal või vasemal poolel.
English: STEMI type of heart attack if you are under 75 years old:
Estonian: STEMI tüüpi infarkt, kui olete alla 75-aastane:
English: • Your doctor will normally ask you to take aspirin (acetylsalicylic acid) as well.
Estonian: • tavaliselt palub arst teil lisaks võtta atsetüülsalitsüülhapet (aspiriini),
English: Do not use this medicine after the expiry date which is stated on the label and carton.
Estonian: Ärge kasutage seda ravimit pärast kõlblikkusaega, mis on märgitud etiketil ja karbil.